Economic burden of antimicrobial resistance: an analysis of additional costs associated with resistant infections
Health Information and Quality Authority (HIQA)
Record ID 32018001680
English
Authors' objectives:
The purpose of this study was to estimate the current costs associated with selected antimicrobial-resistant micro-organisms of public health concern in the public acute hospital setting in Ireland. The perspective adopted is that of the publicly funded health and social care system in Ireland
Details
Project Status:
Completed
URL for project:
https://www.hiqa.ie/reports-and-publications/health-technology-assessment/economic-burden-antimicrobial-resistance
Year Published:
2021
URL for published report:
https://www.hiqa.ie/sites/default/files/2021-07/Report-of-Economic-Burden-of-AMR.pdf
Requestor:
Department of Health
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Ireland
MeSH Terms
- Drug Resistance, Bacterial
- Health Care Costs
- Hospital Costs
- Cost of Illness
- Bacterial Infections
- Anti-Bacterial Agents
Keywords
- Antimicrobial resistance
- Costs
Contact
Organisation Name:
Health Information and Quality Authority (HIQA)
Contact Address:
Health Information and Quality Authority, George's Court, George's Lane,Smithfield, Dublin 7. PH : + 353 (01) 814 7464
Contact Name:
info@hiqa.ie
Contact Email:
info@hiqa.ie
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.